Changes of Cognitive Function before and after Magnesium Valproate Sustained Release Tablets Treatment on Epileptic Children
- VernacularTitle:癫患儿服用丙戊酸镁缓释片治疗前后认知功能的变化
- Author:
yan, HE
;
zheng, ZHAO
;
tian-rong, GUO
;
xia-hong, WANG
;
jun-lin, MU
- Publication Type:Journal Article
- Keywords:
epileptic;
child;
magnesium valproate sustained release tablets;
cognitive function
- From:Journal of Applied Clinical Pediatrics
2006;0(24):-
- CountryChina
- Language:Chinese
-
Abstract:
Objective To observe the effect of magnesium valproate sustained release tablets on children with epilepsy and its effects on cognitive function.Methods Magnesium valproate sustained release tablets were conducted on 38 cases.Close attention was paid to both the degree of paroxysm control and side effects during treatment while periodic examinations on liver function and blood routine were also conducted.The intelligence and P300 of children with epileptics were respectively measured before and after 6-month treatment.Forty children of control group was set up.Results Eighteen cases were totally under controlled(47.4%),11 obviously effect(28.9%),6 effect(15.8%).The total effective rate in total was 92.1%.Obvious differencees in intelligence between children with epileptics and control group before and after 6-month treatment were observed(all P0.05).Conclusions Magnesium valproate sustained release tablets is a new type of broad-spectrum anti-epileptic drug,which has an obvious effect on treatment of children with epileptic without any obvious adverse reaction.It imposes little influence on children′s cognitive function.
